-
Avextra Signs Distribution Agreements with Pharmaceutical Partners and Commences Exports of Cannabis-based Medicines to Switzerland and Austria
Bensheim, 14.9.2022 – Eurox has rebranded as Avextra. The leading manufacturer of cannabis-based medicines Made in Germany will premiere under its new name at the Expopharm Pharmacists’ Congress in Munich from September 14 to 17, 2022…
-
Avextra Continues its European Expansion, Successfully Exporting Medical Cannabis Extracts to Italy
Bensheim, 14.9.2022 – Eurox has rebranded as Avextra. The leading manufacturer of cannabis-based medicines Made in Germany will premiere under its new name at the Expopharm Pharmacists’ Congress in Munich from September 14 to 17, 2022…
-
Germany unveils scaled-down recreational cannabis legalization plan
Marla Luther is the new Chief Strategy Officer at Eurox Pharma, the leading European vertically-integrated manufacturer of cannabis-based medicines, which will operate under the Avextra name.
-
Avextra AG Announces Closing of EU 17 Million Capital Raise
Bensheim, 14.9.2022 – Eurox has rebranded as Avextra. The leading manufacturer of cannabis-based medicines Made in Germany will premiere under its new name at the Expopharm Pharmacists’ Congress in Munich from September 14 to 17, 2022…
-
Avextra Successfully Exports Oil-Based Cannabis Medicines to the United Kingdom
Bensheim, Gemünden (Wohra) and Gauting, 09. November 2022 – Together these three partners will develop a pathway for the first cannabis inhalers to comply with European Medical Device Regulations…
-
Medical Device Submission for a Cannabis Extract Inhaler
Bensheim, Gemünden (Wohra) and Gauting, 09. November 2022 – Together these three partners will develop a pathway for the first cannabis inhalers to comply with European Medical Device Regulations…
-
Eurox has rebranded as Avextra
Bensheim, 14.9.2022 – Eurox has rebranded as Avextra. The leading manufacturer of cannabis-based medicines Made in Germany will premiere under its new name at the Expopharm Pharmacists’ Congress in Munich from September 14 to 17, 2022. The name Avextra emphasises the company’s clear focus on the highest quality cannabis extracts and its commitment to the…
-
New board member at Eurox AG: Marla Luther is Chief Strategy Officer
Marla Luther is the new Chief Strategy Officer at Eurox Pharma, the leading European vertically-integrated manufacturer of cannabis-based medicines, which will operate under the Avextra name.
-
A syringe full of cannabis – FAZ
One of Germany’s largest daily newspapers FAZ has published a portrait on Eurox Group, highlighting our pharmaceutical and business accomplishments.
-
Good Business with Grass – Metropol April/May 2022
Medical cannabis has been allowed to be prescribed to patients for five years. Several start-ups from the Rhine-Main region have been involved since the beginning – and hope for further legalization.
